Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

Bone Marrow Transplantation

Volumn 43, Issue 5, 2009, Pages 365-373

  Bautista, G ^a   Cabrera, J R ^a   Regidor, C ^a   Fores R ^a   Garcia Marco J A ^a   Ojeda, E ^a   Sanjuan I ^a   Ruiz, E ^a   Krsnik, I ^a   Navarro, B ^a   Gil, S ^a   Magro, E ^a   de Laiglesia, A ^a   Gonzalo Daganzo, R ^a   Martin Donaire T ^a   Rico, M ^a   Millan I ^a   Fernandez M N ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZITHROMYCIN; BUSULFAN; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FANSIDAR; FLUCONAZOLE; FLUDARABINE; FOLIC ACID; GANCICLOVIR; IMMUNOGLOBULIN; LINFOGLOBULINA; MEROPENEM; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; TIMOGLOBULINA; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PNEUMOCYSTOSIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; THROMBOCYTE; TOXOPLASMOSIS;

ADOLESCENT; ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; TISSUE DONORS;

EID: 62549086035     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.329     Document Type: Article

References (33)

1. Fernandez MN, Regidor C, Cabrera R, Garcia-Marco JA, Briz M, Fores R et al. Cord blood transplants: Early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 2001; 28: 355-363.
2. Fernandez MN, Regidor C, Cabrera R, Garcia-Marco JA, Fores R, Sanjuán I et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive cotransplantation of a low number of highly puri.ed peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535-544.
3. Magro E, Regidor C, Cabrera R, Sanjuán I, Forés R, Fernández MN et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults induced by co-infusion of mobilized stem cells from a third party donor. Haematologica 2006; 91: 640-648.
4. Foot AB, Garin YJ, Ribaud P, Devergie A, Derouin F, Gluckman E. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14: 241-245.
5. Arguello JR, Little AM, Pay AL, Gallardo D, RojaS I, Marsh SG et al Mutation detection of typing of polymorphic loci through double strand conformation analysis. Nat Genet 1998; 18: 192-194.
6. Thiede C, Bornhouser M, Oelschlagel U, Brendel C, Leo R, Daxberger H et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification or short tandem repeat markers. Leukemia 2001; 15: 293-306.
7. Gooley TA, Leisering W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1997; 18: 695-706.
8. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-260.
9. Sanz MA. Cord-blood transplantation in patients with leukemia - a real alternative for adults. N Engl J Med 2004; 351: 2328-2330.
10. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow Transplant 2006; 38: 83-93.
11. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Gluckman E et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling: Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846-1854.
12. Rocha V, Cornish J, Sievers EL, Filipvich A, Locatelli F, Gluckman E et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
13. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004; 351: 2265-2275.
14. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Gluckman E. al Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285.
15. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813-3820.
16. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322-1330.
17. Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 2007; 13: 444-453.
18. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Wagner JE et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study. Lancet 2007; 369: 1947-1954.
19. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
20. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar DR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
21. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007; 137: 20-35.
22. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
23. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Wagner JE et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347.
24. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Wagner JE et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064-3070.
25. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Wagner JE, Weisdorf DJ et al. Reduced-intensity allogeneic transplant in patients older than 55 years: Unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008; 14: 282-929.
26. Brunstein C, Weisdorf D, DeFor T, Wagner J. Myeloablation and umbilical cord blood transplantation in 184 patients with leukaemia: Analysis of results at a single-center. EBMT 2008 Annual Meeting Abstracts. Bone Marrow Transplant 2008; 41: S152 (abstract O168).
27. Cutler C, Yeap B, Kao G, Ho V, Alyea E, Koreth J et al. Double umbilical cord blood transplantation using reduced-intensity conditioning: A single-centre experience. EBMT 2008 Annual Meeting Abstracts. Bone Marrow Transplant 2008; 41: S23 (abstract O169).
28. Regidor C, Krsnik I, Forés R, Cabrera R, Bautista G, Fernandez MN et al. CD34+ and CFU data from post-thaw controls should be provided to transplant centres by the cord blood banks to facilitate selection of umbilical cord blood units for transplants. EBMT 2008 Annual Meeting Abstracts. Bone Marrow Transplant 2008; 41: S23 (abstract P593).
29. Rauser G, Einsele H, Sinzger C, Wernet D, Kuntz G, Assenmacher M et al. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004; 103: 3565-3572.
30. Ruggeri L, Mancusi A, Perruccio K, Burchielli E, Martelli MF, Velardi A. Natural killer cell alloreactivity for leukemia therapy. J Immunother 2005; 28: 175-182.
31. Vianello F, Dazzi F. Mensenchymal stem cells for graft-versus-host disease: A double edged sword? Leukemia 2008; 22: 463-465.
32. Willemze R, Arrais Rodrigues C, Labopin M, Ionescu I, Boudjedir K, Sanz G et al. Inhibitory KIR-ligand mismatching is associated with decreased incidence of relapse and improved disease free survival after unrelated cord blood stem cell transplantation for patients with acute leukaemia. EBMT 2008 Annual Meeting Abstracts. Bone Marrow Transplant 2008; 41: S1 (abstract).
33. Schöttker B, Feuchtinger T, Schumm M, Klinker E, Handgretinger R, Einsele H et al. Five donors-one recipient: Modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nat Clin Pract Oncol 2008; 5: 291-295.